LOADING
Comparing Johnson & Johnson (JNJ) and Qualcomm Inc (QCOM) across the Health Care and Technology sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | JNJ | QCOM |
|---|---|---|
| Price | $227.50 | $148.85 |
| Change Today | -1.37% | +11.12% |
| Market Cap | $555.2B | $143.1B |
| P/E Ratio | 26.7 | 26.9 |
| Forward P/E | 20.0 | 12.5 |
| PEG Ratio | 3.01 | 0.59 |
| EPS | $8.63 | $4.97 |
| Revenue Growth (YoY) | 9.9% | 5.0% |
| Profit Margin | 21.8% | 12.0% |
| Return on Equity | 35.0% | 21.5% |
| Dividend Yield | 2.30% | 2.59% |
| Beta | 0.33 | 1.28 |
| 52-Week High | $251.71 | $203.60 |
| 52-Week Low | $142.16 | $121.99 |
| Volume | 6.1M | 29.4M |
Johnson & Johnson is the larger company by market capitalization. Johnson & Johnson trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Qualcomm Inc offers a higher dividend yield for income investors. Johnson & Johnson has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.